Editor’s note: The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical ...

Patients with diabetes mellitus who use GLP-1 RAs have an increased risk for acute and chronic pancreatitis, according to a study presented at DDW 2025.

Eraglusib with gemcitabine and nab-paclitaxel achieved statistical significance in the first-line treatment of metastatic ...

In the United States, breast, colorectal, endometrial, pancreatic, and kidney cancers are becoming increasingly common among people under age 50, according to a new study.

Lower odds of receiving key components of quality care seen for those with high overall social vulnerability index.

Between 2000 and 2021, there was an increased incidence of pancreatic adenocarcinoma and a decrease in the incidence of colorectal cancer seen across age groups. HealthDay News — From 2000 to ...

Molecular Imaging Center, Department of Molecular Biotechnologies and Health Sciences, University of Torino, Via Nizza 52, Torino 10126, Italy ...

The researchers identified 275,273 cases of pancreas adenocarcinoma from 2000 to 2021. The annual percentage change (APC) for pancreatic adenocarcinoma was 4.35 among those aged 15 to 34 years ...

Between 2000 and 2021, the incidence of pancreatic adenocarcinoma increased across all age groups, with the highest annual percentage change (APC) of 4.35% in individuals aged 15–34 years.

James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University Comprehensive Cancer Center, Columbus, OH, United States Pancreatic Ductal Adenocarcinoma (PDAC) accounts for ...

Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease with a dismal prognosis. It is the 9th most common cancer, and the 3rd leading cause of mortality in cancer patients in the United ...